ETR:AFX - Carl Zeiss Meditec Stock Price, Forecast & News

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

Carl Zeiss Meditec is scheduled to release their next quarterly earnings announcement on Monday, May 11th 2020. View Earnings Estimates for Carl Zeiss Meditec.

8 analysts have issued twelve-month price targets for Carl Zeiss Meditec's shares. Their forecasts range from €80.00 to €140.00. On average, they anticipate Carl Zeiss Meditec's stock price to reach €111.14 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View Analyst Price Targets for Carl Zeiss Meditec.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.

Press coverage about AFX stock has trended neutral on Tuesday, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Carl Zeiss Meditec earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Carl Zeiss Meditec.

Some companies that are related to Carl Zeiss Meditec include Sartorius (SRT), Integral Diagnostics (IDX), Akumin (AKU), Volpara Health Tech (VHT), Profound Medical (PRN), Senseonics (SENS), Exagen (XGN), Renalytix Ai (RENX), Palatin Technologies (PTN), Oncosil Medical (OSL), Yourgene Health (YGEN), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1) and Sernova (SVA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Adaptimmune Therapeutics (ADAP), Ocular Therapeutix (OCUL), QuinStreet (QNST), Rigel Pharmaceuticals (RIGL), Bemis (BMS), Fresenius Medical Care AG & Co. (FMS), MCCORMICK & CO /SH (MKC), Resideo Technologies (REZI), Versum Materials (VSM) and Great Western Mining (GWMO).

One share of AFX stock can currently be purchased for approximately €103.70.

Carl Zeiss Meditec has a market capitalization of $9.27 billion and generates $1.51 billion in revenue each year. Carl Zeiss Meditec employs 3,179 workers across the globe.View Additional Information About Carl Zeiss Meditec.

The official website for Carl Zeiss Meditec is http://www.zeiss.com/.

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.